We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.7B
AUM Growth
+$103M
Cap. Flow
-$30.6M
Cap. Flow %
-1.8%
Top 10 Hldgs %
33.08%
Holding
539
New
21
Increased
53
Reduced
85
Closed
50
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
451
Strategy Inc
MSTR
$38.4B
$1.61K ﹤0.01%
5
SCI icon
452
Service Corp International
SCI
$11.6B
$1.5K ﹤0.01%
18
DELL icon
453
Dell
DELL
$293B
$1.42K ﹤0.01%
10
NUTX
454
Nutex Health
NUTX
$1.11B
$1.34K ﹤0.01%
13
NIO icon
455
NIO
NIO
$11.9B
$1.33K ﹤0.01%
175
TDG icon
456
TransDigm Group
TDG
$67.7B
$1.32K ﹤0.01%
1
ONON icon
457
On Holding
ONON
$12.5B
$1.27K ﹤0.01%
30
SMH icon
458
VanEck Semiconductor ETF
SMH
$73.2B
$1.18K ﹤0.01%
4
BSJP
459
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$1.15K ﹤0.01%
50
-1,500
-97% -$34.6K
SHEL icon
460
Shell
SHEL
$245B
$1.07K ﹤0.01%
15
FANG icon
461
Diamondback Energy
FANG
$52.7B
$1K ﹤0.01%
7
BHF icon
462
Brighthouse Financial
BHF
$3.5B
$956 ﹤0.01%
18
GRWG icon
463
GrowGeneration
GRWG
$90.7M
$935 ﹤0.01%
500
TKR icon
464
Timken Company
TKR
$9.03B
$903 ﹤0.01%
12
LULU icon
465
lululemon athletica
LULU
$14.6B
$890 ﹤0.01%
5
IR icon
466
Ingersoll Rand
IR
$33.7B
$827 ﹤0.01%
10
NBIX icon
467
Neurocrine Biosciences
NBIX
$16.6B
$702 ﹤0.01%
5
BIIB icon
468
Biogen
BIIB
$30.7B
$701 ﹤0.01%
5
STZ icon
469
Constellation Brands
STZ
$23.2B
$674 ﹤0.01%
5
OXY icon
470
Occidental Petroleum
OXY
$55.9B
$473 ﹤0.01%
10
-306
-97% -$13.8K
IP icon
471
International Paper
IP
$22B
$464 ﹤0.01%
10
LUV icon
472
Southwest Airlines
LUV
$23B
$160 ﹤0.01%
5
TD icon
473
Toronto Dominion Bank
TD
$200B
$160 ﹤0.01%
2
DDD icon
474
3D Systems Corp
DDD
$613M
$145 ﹤0.01%
50
PSX icon
475
Phillips 66
PSX
$81.4B
$137 ﹤0.01%
1

Similar funds

Atwood & Palmer's Q3 2025 Portfolio in Review

As of Q3 2025, Atwood & Palmer held 539 positions worth $1.7B, up 6.4% from $1.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Atwood & Palmer's Q3 2025 filing shows 21 new, 53 increased, 85 reduced and 50 closed positions. Its largest new stake was Agilon Health: 8,400 shares worth $216K. The largest sale was Palantir, an estimated $34.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Atwood & Palmer's largest Q3 2025 buy was Agilon Health: 8,400 shares worth $216K.
  • Atwood & Palmer added most to Janus Henderson Emerging Markets Debt Hard Currency ETF in Q3 2025, an estimated $1.35M increase.
  • Atwood & Palmer's biggest Q3 2025 reduction was Palantir, cutting an estimated $34.3M.
  • Atwood & Palmer fully exited Sitio Royalties in Q3 2025, selling an estimated $52K.
  • Atwood & Palmer's ten largest holdings make up 33% of its $1.7B portfolio in Q3 2025.
  • Atwood & Palmer opened 21 new positions and closed 50 in Q3 2025.
  • Atwood & Palmer's portfolio value rose 6.4% quarter-over-quarter to $1.7B.

Based on Atwood & Palmer's 13F filing for Q3 2025, filed 15 Oct 2025.